KBLB · Kraig Biocraft Laboratories, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements, the Company has a working capital deficiency of $7,326,899 and stockholders' deficiency of $6,751,116 and used $1,128,413 of cash in operations for the six months ended June 30, 2026. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company's ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Every disclosed holder of KBLB in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns KBLB
13F quarter Mar 31, 2026| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 62,952 | 0.01% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 0 | 0.00% |
| Remaining | 1,115,271,118 | 99.99% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 1,115,334,070, the issuer's latest cover-page count restated onto today's split basis.
Insiders are listed but not summed: the issuer has more than one class of common stock and Forms 3, 4 and 5 report one issuer-wide balance across them.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of KBLB
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
Thompson Kimberly Kraig
Insider
CIK 1837586 · Mar 31, 2025
Director, Chief Executive Officer, 10% Owner, issuer-wide, not summed
|
201,677,922 | ||
| 2 |
Rice Jonathan Richard
Insider
CIK 1837403 · May 27, 2025
Chief Operating Officer, issuer-wide, not summed
|
5,692,836 | ||
| 3 |
Hurley Capital, LLC
13F
CIK 1632844 · Registered investment adviser · Mar 31, 2026
|
50,000 | ||
| 4 |
McIlrath & Eck, LLC
13F
CIK 1701714 · Registered investment adviser · Mar 31, 2026
|
12,952 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.